Micro biology 1 Flashcards
Upper RS infections include
Pharyngitis
sinusitis
tonsilitis
otitis media
middle RS infection include
epiglottitis laryngitis tracheitis bronchitis bronchiolitis croup / laryngotracheobronchitis
lower RS infection include
infection in lung parenchyma / pneumonia
rhinitis caused by , minor feature and what season is it common in
viral (rhinovirus then coronavirus )
minor feature is fever
humid szn
rhinitis typically present as
common cold
sinusitis caused by
viral but in odontogenic infections and immunocompromised fungal and bacterial infecs(H. inflenza , s. pneumonia and M . catarrhalis)
purulent discharge feature of sinusitis
true
sinusitis divided into
acute (recurrent)
chronic
pharyngitis mainly caused by
viral
what are you supposed to do when you discover a case of pharyngitis
rule out s. pyogenes due to sequelae (RF and GN)
Viral pharyngitis common in
4-7 years
what is otitis media
inflammation of mucosa in middle ear periosteum
otitis media mainly caused by
H. inflenza , s. pneumonia and M . catarrhalis
chronic cases caused by and its symp.
p.aeuriginsoa, enterobacterales and anaerobe
ear discharge and hearing loss
what is laryngitis and its symptoms
inflammation in laryngeal mucosa
voice hoarseness and stridor
laryngotracheobronchitis mucosal inflammation extending below ?
glottis
croup most common in what age group and caused by
1-2 yrs
parainfluenza 1,2 ,3
rhinovirus and adenovirus
Influenza and RSV
Clinically Croup
barking cough and stridor and hoarseness
differentiate croup from
Foreign body and acute epiglottitis
tracheitis part of viral disease of larynx and larynx usually
true
most cases of tracheitis associated with
s. aureus
treacheitis affects children at larger age group than croup
true
tracheitis has similar presentation to croup but …..
higher temp and thick purulent secretion
bronchitis types and causes
acute viral or atypical bacterial
chronic ; non infec, like smoking and pollution
acute excerbation of chronic bronchitis caused by
h. inflenza , s. pneumonia and M . catarrhalis)
bronchiolitis busually caused by
RSV
RSV bronchiolitis peaks in
winter
age group of bronchiolitis
2-10 mths
bronchiolitis clinical
history of URT infec with mild fever then 2-3 days symp of lower RT (cough , breathlessness and wheeze)
differential diagnosis of bronchiolitis
asthma or foreign body
pleuritic chest pain due to
pneumonia
picornaviridie member
rhinovirus
pneumoviridie members
RSV and hMPV
orthomyxoviridie member
influenza
paramyxoviridie member
parainfluenza
what viruses has negative sense ssRNA
orthomyxovirdae and paramyxovirdae and pneumovirdae
what viruses has positive sense ssRNA
coronaviradae and picornavirdae
what viruses has linear dsdna
adenovirdae
what virus has genome segmented into 7-8
orthomyxovirdae
what viruses dont have an envelope
adenovirus and picornavirdae
what is the major cause of rhinitis / common cold in all age groups
rhinovirus
rhinitis mostly in what seasons
spring and autumn
is there antiviral therapy or vaccine against rhinovirus
no
coronavirdae divided into how many groups
alpha beta gamma delta
what and how many coronaviruses implicated in global pandemics
3 beta
major ultrastructural feature of SARS COV 2 and what it does
s protein (spike) and it bind to ACE 2 on pneumocyte 1
mutations in SARS COV 2 genome leads to what
appearance of VOC
can presymp. transmission occur in covid 19
yes 2 days before symptoms
immunocomp patient that tested positive and has non severe infection for how long will they transmit the virus
after 10 days of onset of illness they stop
incubation period of covid 19 and the average period
14 days
4-5 days
SARS COV 2 passes through how many stages and each lasting adeh
3
5-7 days
stage I / mild of SARS COV 2 imp things
taste and smell disturbances
URT involevement
no dyspnea
normal chest xray
stage II / moderate of SARS COV 2 imp things
radiological changes and dyspnea
two types IIA without hypoxia and IIB with hypoxia
stage III/ severe of SARS COV 2 imp things
systemic hyperinflamation
elevation in IL-2 IL-6 IL-7 G-CSF TNFA CRP
Treatment of mild cases of SARS COV 2
Symptomatic as outpatient like antipyretic or analgesic
Treatment of ppl at risk of SARS COV 2
antiviral; molnupiravir
monoclonal ab ; casirimivab imdevimab
Treatment of severe cases of SARS COV
antiviral; remedesivir supportive therapy monoclonal ab in oxygen req :dexamethasone / glucocorticoid jak pathway inhib (barecitinib) il-6 pathway inhib (tocilizumab)
vaccines of sars cov 2
viral vector ; johnson and johnson , sputnik and astrazeneca
mrna : pfizer and moderna
inactivated ; sinopharm
influenza virus A affects and severity
wide host range and cause severe disease that leads to pandemics
influenza virus B affects and severity
humans only rare epidemics
influenza virus C affects and severity
humans and swine
little epidemic potential
virion of influenza A B C
A and B 8 seg
C 7 seg
glycoproteins on influenza envelope
HA (hemagglutinin ) for viral entry
NA ( neuraminadase) for viral release
what serotype of influenza has no NA
C
where does influenza virus replicate
in nucleus
how does influenza virus change its antigenic makeup
antigenic drift ; cumulative mutation during replication
antigenic shift ; reassortment of gene segments when different viral strains infect the same host cell (co infec)
where is antigenic shift only seen
influenza type A
what is influenza
a clinical syndrome caused by influenza A and b to respiratory tract
according to outbreak pattern divide influenza
seasonal / epidemic usually in winter
pandemic
acute influenza symptoms in adult and child
adult ; after incubation period prodrome malaise nd headache for few hours then classical flu
children ; middle and lower RS involvement and GI symptoms with higher fever
incubation period of influenza
1-4 days
uncomplicated flu resolves in
7-10 days
influenza more sever in child or adult
child
lab diagnosis (RT PCR) for influenza diagnosis used for
high risk population or hospitalized
cell culture for influenza for
epidemiological purposes
flu primarily treated by
supportive (NSAID , decongestion and hydration)
antiviral therapy for flu
oseltamivir and zanamivir are NA inhib against A nd B
amantidine and rimantidine prevent uncoating ONLY FOR A
available flu formulation for influenza
injectable inactivated and intranasal live attenuated
how many parainfluenza serotypes pathognemic to humans
4
infection of parainfluenza 1 and 2 during what season and 3
1 and 2 autumn
3 all year
is there any medications of vaccines for parainfluenza and rhinovirus
no
what virus causes diseases that the severity decrease with age
RSV
febrile rhinitis and pneumonia below 1 and cold symptoms in older
What virus cause bronchiolitis and pneumona below 1 year
RSV
RSV most common during what season
winter
severe case of RSV treated by
guanosine analogue ( ribavirin)
can RSV prevented in high risk infants
yes by anti RSV MAB
pharyngoconjuctival fever caused by what serotypes of adeno
3 and 7
pertussis like caused by what serotypes of adeno
3 and 19
pneumonia caused by what serotypes of adeno
3 and 7 a and 7 b and 14
outbreaks in military recruits caused by what serotypes of adeno
4
what is used to treat adenovirus
cidofovir to treat adenoviral pneumona in immunocomprimised
vaccines against adeno serotypes where are they found
military camps